SCHEMBL367192

SCHEMBL367192

CC(C)NCC[O]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL95612 0.81
SCHEMBL366540 0.79
SCHEMBL272858 0.78 TDP1 (0.36)
SCHEMBL7952689 0.75
Hydrochloric Acid SCHEMBL13859290 0.74 ABCC3 (0.36)
SCHEMBL30843185 0.74 TDP1 (0.33)
SCHEMBL17571696 0.73
Bromide SCHEMBL6659970 0.72 TDP1 (0.31)
SCHEMBL616846 0.72
SCHEMBL479263 0.72 HRH4 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190091235-A1 COMPOSITIONS AND THERAPEUTIC METHODS FOR THE TREATMENT OF COMPLEMENT-ASSOCIATED DISEASES HEPALINK (HONG KONG) LIMITED (HK) 2019-03-28 US claimed
US-10111885-B2 Compositions and therapeutic methods for the treatment of complement-associated diseases RESVERLOGIX CORP. (CA) 2018-10-30 US claimed
EP-3268007-A1 COMPOSITIONS AND THERAPEUTIC METHODS FOR THE TREATMENT OF COMPLEMENT-ASSOCIATED DISEASES Resverlogix Corp. (CA) 2018-01-17 EP claimed
WO-2016147053-A1 COMPOSITIONS AND THERAPEUTIC METHODS FOR THE TREATMENT OF COMPLEMENT-ASSOCIATED DISEASES RESVERLOGIX CORP. (CA) 2016-09-22 WO claimed
US-20160263126-A1 COMPOSITIONS AND THERAPEUTIC METHODS FOR THE TREATMENT OF COMPLEMENT-ASSOCIATED DISEASES HEPALINK (HONG KONG) LIMITED (HK) 2016-09-15 US claimed
CN-114423742-B Benzotriazole-based compound, light absorber and resin composition 三井化学株式会社 2024-05-28 CN disclosed
CN-117466830-A Benzotriazole-based compound, light absorber and resin composition 三井化学株式会社 2024-01-30 CN disclosed
WO-2024005030-A1 DIPHENYLETHENE-BASED COMPOUND, LIGHT ABSORBER, RESIN COMPOSITION, AND USE THEREOF 山本化成株式会社 2024-01-04 WO disclosed
US-20230331724-A1 PROCESSES FOR PREPARING A DIAZABICYCLOOCTANE COMPOUND MEIJI SEIKA PHARMA CO., LTD. (JP) 2023-10-19 US disclosed
US-11731971-B2 Processes for preparing a diazabicyclooctane compound MEIJI SEIKA PHARMA CO., LTD. (JP) 2023-08-22 US disclosed
CN-114423742-A Benzotriazole compound, light absorber, and resin composition 三井化学株式会社 2022-04-29 CN disclosed
US-20210371419-A1 PROCESSES FOR PREPARING A DIAZABICYCLOOCTANE COMPOUND MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-12-02 US disclosed
EP-0375791-A1 Phenyl ethanol amines, their use as pharmaceutical compounds and as performance stimulants in animals, as well as processes for their preparation BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 1990-07-04 EP disclosed
WO-1990006299-A1 NEW PHENYLETHANOLAMINES BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 1990-06-14 WO disclosed
US-4886814-A LOWER BLOOD SUGAR DR. KARL THOMAS GMBH (DE) 1989-12-12 US disclosed
EP-0330017-A2 Use of thiazoles for increasing animal performance BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 1989-08-30 EP disclosed
US-4562211-A ANTIDEPRESSANTS MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) 1985-12-31 US disclosed
US-4091114-A ANTIDEPRESSANTS MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JA) 1978-05-23 US disclosed
US-4060641-A ANTIDEPRESSANT MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) 1977-11-29 US disclosed
US-4024282-A Pharmaceutically active 2-(3-alkylaminopropoxy)diphenylmethanes MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) 1977-05-17 US disclosed